Amino Acid, Peptide, or Protein: cabotegravir

Medical news and research articles

How a new long-acting HIV drug combo tackles resistance

A new long-acting HIV treatment could expand options for people who have trouble taking daily pills and whose virus is resistant to some commonly used HIV drugs, according to a new UC San Francisco study.

US approves Gilead's twice-yearly injection to prevent HIV

The US Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV—a move the company hailed as a major breakthrough in the fight against the sexually transmitted virus.

page 1 from 2